Pliant Therapeutics Inc. (PLRX)
1.18
-0.01 (0.84%)
Upcoming Events
Latest Headlines
Form 4 PLIANT THERAPEUTICS, For: Jun 11 Filed by: MCCOURT Thomas A
June 12, 2026 5:02 PM - SEC Filing
Form 4 PLIANT THERAPEUTICS, For: Jun 11 Filed by: CROWELL GAYLE A
June 12, 2026 5:01 PM - SEC Filing
Form 4 PLIANT THERAPEUTICS, For: Jun 11 Filed by: Krognes Steve E.
June 12, 2026 5:01 PM - SEC Filing
Form 4 PLIANT THERAPEUTICS, For: Jun 11 Filed by: Huh Hoyoung
June 12, 2026 5:01 PM - SEC Filing
Form 4 PLIANT THERAPEUTICS, For: Jun 11 Filed by: Curnutte John T
June 12, 2026 5:01 PM - SEC Filing
Form 4 PLIANT THERAPEUTICS, For: Jun 11 Filed by: Cline Darren S
June 12, 2026 5:01 PM - SEC Filing
Form 8-K PLIANT THERAPEUTICS, For: Jun 11
June 11, 2026 4:52 PM - SEC Filing
Pliant Therapeutics to present cancer drug data at ASCO meeting
May 21, 2026 5:36 PM - StreetInsider
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026 5:29 PM - Globe NewsWire
Atisama advances RB042 to phase 1 multi-dose study, names new board chair
May 15, 2026 10:25 AM - StreetInsider
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
May 15, 2026 10:25 AM - PR NewsWire
Form 10-Q PLIANT THERAPEUTICS, For: Mar 31
May 11, 2026 4:11 PM - SEC Filing
Form 8-K PLIANT THERAPEUTICS, For: May 11
May 11, 2026 4:08 PM - SEC Filing
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 11, 2026 4:05 PM - StreetInsider
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
May 6, 2026 8:30 AM - Globe NewsWire
Pliant Therapeutics doses first patient in cancer trial expansion
April 30, 2026 8:30 AM - StreetInsider
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
April 30, 2026 8:30 AM - StreetInsider
Form ARS PLIANT THERAPEUTICS, For: Dec 31
April 22, 2026 4:33 PM - SEC Filing
Form DEFA14A PLIANT THERAPEUTICS,
April 22, 2026 4:32 PM - SEC Filing
Form DEF 14A PLIANT THERAPEUTICS, For: Jun 11
April 22, 2026 4:32 PM - SEC Filing
Pliant reports updated Phase 1 data for PLN-101095 cancer treatment
April 18, 2026 1:31 PM - StreetInsider
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
April 18, 2026 1:31 PM - StreetInsider
Form 4 PLIANT THERAPEUTICS, For: Apr 17 Filed by: Kuo Minnie
April 17, 2026 4:43 PM - SEC Filing
Form 4 PLIANT THERAPEUTICS, For: Apr 17 Filed by: Coulie Bernard
April 17, 2026 4:43 PM - SEC Filing
Form 4 PLIANT THERAPEUTICS, For: Apr 17 Filed by: Cummings Keith Lamont
April 17, 2026 4:43 PM - SEC Filing
Form 4 PLIANT THERAPEUTICS, For: Apr 17 Filed by: Cheung Lily
April 17, 2026 4:43 PM - SEC Filing
Form 8-K PLIANT THERAPEUTICS, For: Apr 14
April 17, 2026 4:31 PM - SEC Filing
Form EFFECT PLIANT THERAPEUTICS,
April 7, 2026 12:37 PM - SEC Filing
Form S-3 PLIANT THERAPEUTICS,
March 30, 2026 5:59 PM - SEC Filing
Form 8-K PLIANT THERAPEUTICS, For: Mar 27
March 30, 2026 5:48 PM - SEC Filing
Full Article List
